About the Fibroid Care Center 

Mount Sinai is one of the few hospitals nationwide with a dedicated Fibroid Care Center. Founded by Harold Mitty, MD, FSIR, emeritus Division Chief, the Division of Interventional Radiology at Mount Sinai was one of the first in the country to employ non-surgical treatment for uterine fibroids. Our goals are to provide women with the information they need to determine the optimal fibroid treatment and offer the safest and most effective therapies available. The Director of the Fibroid Care Center at Mount Sinai, Dr. Scott Nowakowski is a vascular and interventional radiologist who specializes in treating patients with uterine fibroids.

Uterine Fibroids 

Uterine fibroids are benign tumors which can cause symptoms such as excessive bleeding, pain, and disfigurement. If left untreated, the symptoms can persist until menopause, severely impacting a woman's quality of life. Uterine Fibroids affect approximately 25 million women in the U.S. annually, with approximately six million women seeking medical treatment for severe symptoms each year. It is estimated that of the 600,000 hysterectomies performed in the U.S. each year, almost half are performed to treat symptomatic uterine fibroids.

Treatment Options

Approximately 80 percent of women with uterine fibroids do not require treatment. Often monitoring and medications that alleviate symptoms or inhibit growth are sufficient. However, uterine fibroids should be treated if they are cause abnormal heavy bleeding or present other complications due to their size. At the Fibroid Care Center, our highly skilled team of dedicated interventional radiologists (board-certified physicians who specialize in minimally invasive, targeted therapies) offer a minimally invasive procedure called Uterine Fibroid Embolization (UFE) to treat symptomatic uterine fibroids. We work closely with gynecologists throughout the Mount Sinai Health System who offer alternative treatments such as oral contraceptives and/or hormonal therapy, endometrial ablation, myomectomy, and hysterectomy. Our physicians place great emphasis on educating patients and will answer all of your questions about treatment alternatives.

Recent Advances

The Mount Sinai Medical Center is the world's leader in radial artery access for uterine fibroid embolization with over 150 cases performed over the past 3 years. Radial access allows for early ambulation and decreased complications compared to the traditional femoral artery approach. This novel technique has been published and highlighted as a true innovation in the treatment of symptomatic uterine fibroids to minimize the risks of treatment and improve patient satisfaction. Mount Sinai Interventional Radiology has also pioneered the use of "ultra low dose" radiation exposure during uterine fibroid embolization to improve the safety of the procedure for symptomatic women. Our procedures can now be performed with a 65 percent reduction in the x-ray exposure to the patient as compared to procedures performed in 2013.

Contact Us

Fibroid Care Center
The Mount Sinai Hospital
Division of Interventional Radiology
One Gustave L Levy Place
(100th Street and Madison Avenue)
New York, NY 10029
Tel: 212-241-8243 opt#2
Email: fibroidcarecenter@mountsinai.org

Uterine Fibroid Embolization
Consult at 212-241-4046